164 related articles for article (PubMed ID: 29441941)
21. Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Shanghai Aging Study.
Xi J; Ding D; Zhao Q; Liang X; Zheng L; Guo Q; Hong Z; Fu H; Xu J; Xiao Q
Curr Alzheimer Res; 2020; 17(2):185-195. PubMed ID: 32183673
[TBL] [Abstract][Full Text] [Related]
22. An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer's disease.
De Roeck A; Duchateau L; Van Dongen J; Cacace R; Bjerke M; Van den Bossche T; Cras P; Vandenberghe R; De Deyn PP; Engelborghs S; Van Broeckhoven C; Sleegers K;
Acta Neuropathol; 2018 Jun; 135(6):827-837. PubMed ID: 29589097
[TBL] [Abstract][Full Text] [Related]
23. ABCA7 in Alzheimer's Disease.
Zhao QF; Yu JT; Tan MS; Tan L
Mol Neurobiol; 2015; 51(3):1008-16. PubMed ID: 24878767
[TBL] [Abstract][Full Text] [Related]
24. Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European-Americans.
Del-Aguila JL; Fernández MV; Jimenez J; Black K; Ma S; Deming Y; Carrell D; Saef B; ; Howells B; Budde J; Cruchaga C
Alzheimers Res Ther; 2015 Dec; 7(1):73. PubMed ID: 26654793
[TBL] [Abstract][Full Text] [Related]
25. The bridging integrator 1 Gene rs7561528 polymorphism contributes to Alzheimer's disease susceptibility in East Asian and Caucasian populations.
Zhou F; Haina D
Clin Chim Acta; 2017 Jun; 469():13-21. PubMed ID: 28302384
[TBL] [Abstract][Full Text] [Related]
26. rs4147929 variant minor allele increases ABCA7 gene expression and ABCA7 shows increased gene expression in Alzheimer's disease patients compared with controls.
Liu G; Zhang H; Liu B; Wang T; Han Z; Ji X
Acta Neuropathol; 2020 May; 139(5):937-940. PubMed ID: 32112171
[No Abstract] [Full Text] [Related]
27. Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis.
Ma XY; Liu JP; Song ZY
Atherosclerosis; 2011 Apr; 215(2):428-34. PubMed ID: 21310416
[TBL] [Abstract][Full Text] [Related]
28. Genetic association of CALHM1 rs2986017 polymorphism with risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Tan K; Peng J; Zhu Y; Wang X
Neurol Sci; 2016 Apr; 37(4):525-32. PubMed ID: 26700797
[TBL] [Abstract][Full Text] [Related]
29. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Hollingworth P; Harold D; Sims R; Gerrish A; Lambert JC; Carrasquillo MM; Abraham R; Hamshere ML; Pahwa JS; Moskvina V; Dowzell K; Jones N; Stretton A; Thomas C; Richards A; Ivanov D; Widdowson C; Chapman J; Lovestone S; Powell J; Proitsi P; Lupton MK; Brayne C; Rubinsztein DC; Gill M; Lawlor B; Lynch A; Brown KS; Passmore PA; Craig D; McGuinness B; Todd S; Holmes C; Mann D; Smith AD; Beaumont H; Warden D; Wilcock G; Love S; Kehoe PG; Hooper NM; Vardy ER; Hardy J; Mead S; Fox NC; Rossor M; Collinge J; Maier W; Jessen F; Rüther E; Schürmann B; Heun R; Kölsch H; van den Bussche H; Heuser I; Kornhuber J; Wiltfang J; Dichgans M; Frölich L; Hampel H; Gallacher J; Hüll M; Rujescu D; Giegling I; Goate AM; Kauwe JS; Cruchaga C; Nowotny P; Morris JC; Mayo K; Sleegers K; Bettens K; Engelborghs S; De Deyn PP; Van Broeckhoven C; Livingston G; Bass NJ; Gurling H; McQuillin A; Gwilliam R; Deloukas P; Al-Chalabi A; Shaw CE; Tsolaki M; Singleton AB; Guerreiro R; Mühleisen TW; Nöthen MM; Moebus S; Jöckel KH; Klopp N; Wichmann HE; Pankratz VS; Sando SB; Aasly JO; Barcikowska M; Wszolek ZK; Dickson DW; Graff-Radford NR; Petersen RC; ; van Duijn CM; Breteler MM; Ikram MA; DeStefano AL; Fitzpatrick AL; Lopez O; Launer LJ; Seshadri S; ; Berr C; Campion D; Epelbaum J; Dartigues JF; Tzourio C; Alpérovitch A; Lathrop M; ; Feulner TM; Friedrich P; Riehle C; Krawczak M; Schreiber S; Mayhaus M; Nicolhaus S; Wagenpfeil S; Steinberg S; Stefansson H; Stefansson K; Snaedal J; Björnsson S; Jonsson PV; Chouraki V; Genier-Boley B; Hiltunen M; Soininen H; Combarros O; Zelenika D; Delepine M; Bullido MJ; Pasquier F; Mateo I; Frank-Garcia A; Porcellini E; Hanon O; Coto E; Alvarez V; Bosco P; Siciliano G; Mancuso M; Panza F; Solfrizzi V; Nacmias B; Sorbi S; Bossù P; Piccardi P; Arosio B; Annoni G; Seripa D; Pilotto A; Scarpini E; Galimberti D; Brice A; Hannequin D; Licastro F; Jones L; Holmans PA; Jonsson T; Riemenschneider M; Morgan K; Younkin SG; Owen MJ; O'Donovan M; Amouyel P; Williams J
Nat Genet; 2011 May; 43(5):429-35. PubMed ID: 21460840
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's Disease Genetics and ABCA7 Splicing.
Vasquez JB; Simpson JF; Harpole R; Estus S
J Alzheimers Dis; 2017; 59(2):633-641. PubMed ID: 28655137
[TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of the effect of ABCA1 R219K polymorphism on the risk of coronary heart disease.
Li Y; Tang K; Zhou K; Wei Z; Zeng Z; He L; Wan C
Mol Biol Rep; 2012 Feb; 39(2):1809-13. PubMed ID: 21643759
[TBL] [Abstract][Full Text] [Related]
32. Understanding the function of ABCA7 in Alzheimer's disease.
Li H; Karl T; Garner B
Biochem Soc Trans; 2015 Oct; 43(5):920-3. PubMed ID: 26517904
[TBL] [Abstract][Full Text] [Related]
33. Association between EXOC3L2 rs597668 polymorphism and Alzheimer's disease.
Shang H; Fu J; Zhang XM; Song RR; Wang WZ
CNS Neurosci Ther; 2013 Oct; 19(10):834-9. PubMed ID: 23663385
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese.
Wang F; Jia J
Brain Res; 2007 May; 1147():34-8. PubMed ID: 17335784
[TBL] [Abstract][Full Text] [Related]
35. The Alzheimer's disease GWAS risk alleles in the ABCA7 promoter and 5' region reduce ABCA7 expression.
Lyssenko NN; Shi X; Praticò D
Acta Neuropathol; 2022 Sep; 144(3):585-587. PubMed ID: 35759012
[No Abstract] [Full Text] [Related]
36. Association between ABCA7 gene polymorphisms and Parkinson's disease susceptibility in a northern Chinese Han population.
Yang Z; Xue L; Li C; Li M; Xie A
Neurosci Lett; 2022 Jul; 784():136734. PubMed ID: 35709878
[TBL] [Abstract][Full Text] [Related]
37. Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease.
Kunkle BW; Carney RM; Kohli MA; Naj AC; Hamilton-Nelson KL; Whitehead PL; Wang L; Lang R; Cuccaro ML; Vance JM; Byrd GS; Beecham GW; Gilbert JR; Martin ER; Haines JL; Pericak-Vance MA
Neurosci Lett; 2017 May; 649():124-129. PubMed ID: 28400126
[TBL] [Abstract][Full Text] [Related]
38. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
[TBL] [Abstract][Full Text] [Related]
39. CYP46A1 intron-2T/C polymorphism and Alzheimer's disease: an updated meta-analysis of 16 studies including 3,960 cases and 3,828 controls.
Li M; Wang W; Li Y; Wang L; Shen X; Tang Z
Neurosci Lett; 2013 Aug; 549():18-23. PubMed ID: 23792195
[TBL] [Abstract][Full Text] [Related]
40. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.
Karch CM; Jeng AT; Nowotny P; Cady J; Cruchaga C; Goate AM
PLoS One; 2012; 7(11):e50976. PubMed ID: 23226438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
